A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder
Year: 2018
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
DOI: 10.4088/jcp.17m12058
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: brexpiprazole, major depressive disorder, adjunctive therapy, antidepressant-refractory depression, atypical antipsychotics, treatment-resistant depression, anxious distress, functional disability, tolerability, fixed-dose dosing, Montgomery-Asberg Depression Rating Scale, Sheehan Disability Scale, outpatients, adults with depression, inadequate response to antidepressants
Open Access status: closed
OpenAlex ID: W2803445534
